Detalles de la búsqueda
1.
[Efficacy analysis of Venetoclax combined with TKI and dexamethasone-containing low-dose chemotherapy for relapsed/refractory Ph+acute B-lymphoblastic leukemia].
Zhonghua Yi Xue Za Zhi
; 102(10): 745-748, 2022 Mar 15.
Artículo
en Zh
| MEDLINE | ID: mdl-35280020
2.
[The safety and efficacy of low dose subcutaneous decitabine combined with arsenic trioxide in patients with inermediate or higer-risk myelodysplastic syndrome].
Zhonghua Nei Ke Za Zhi
; 58(12): 908-910, 2019 Dec 01.
Artículo
en Zh
| MEDLINE | ID: mdl-31775455
3.
[Efficacy and prognosis of the dynamic monitoring lymphocyte to monocyte ratio in patients with diffuse large B-cell lymphoma].
Zhonghua Yi Xue Za Zhi
; 99(40): 3139-3144, 2019 Oct 29.
Artículo
en Zh
| MEDLINE | ID: mdl-31694104
4.
[Long-term clinical outcome of children and adolescents with Burkitt's lymphoma treated with rituximab combined with modified NHL-BFM-90 regimen].
Zhonghua Yi Xue Za Zhi
; 99(8): 605-610, 2019 Feb 26.
Artículo
en Zh
| MEDLINE | ID: mdl-30818930
5.
[The clinical safety and efficacy of low dose subcutaneous decitabine in treating acute myeloid leukemia and intermediate- or higer-risk myelodysplastic syndromes in the elderly patients].
Zhonghua Nei Ke Za Zhi
; 56(8): 606-609, 2017 Aug 01.
Artículo
en Zh
| MEDLINE | ID: mdl-28789495
6.
[Clinical characteristics and analysis of patients with hematological diseases and HCV-Ab positive].
Zhonghua Yi Xue Za Zhi
; 97(40): 3162-3165, 2017 Oct 31.
Artículo
en Zh
| MEDLINE | ID: mdl-29081163
7.
[Thalidomide combined with interferon and interleukin-2 in treatment of relapsed or refractory acute myelogenous leukemia].
Zhonghua Nei Ke Za Zhi
; 55(11): 875-877, 2016 Nov 01.
Artículo
en Zh
| MEDLINE | ID: mdl-27801345
8.
[Anaplastic lymphoma kinase positive anaplastic large cell lymphoma with cardiac infiltration: a case report].
Zhonghua Zhong Liu Za Zhi
; 42(4): 351-352, 2020 04 23.
Artículo
en Zh
| MEDLINE | ID: mdl-32375454
9.
[The clinical pathological features and therapeutic effects of 8 cases of lymphoma treat-related acute myeloid leukemia].
Zhonghua Zhong Liu Za Zhi
; 41(7): 533-534, 2019 07 23.
Artículo
en Zh
| MEDLINE | ID: mdl-31357841
10.
[Targeted immunotherapy efficacy analysis in patients with relapsed/refractory B cell acute lymphocytic leukemia].
Zhonghua Xue Ye Xue Za Zhi
; 43(11): 946-951, 2022 Nov 14.
Artículo
en Zh
| MEDLINE | ID: mdl-36709187
11.
[Safety and efficacy of patients with refractory B-lymphoblastic leukemia treated with anti-CD19 CAR-T cell bridging to allogeneic hematopoietic stem cell transplantation].
Zhonghua Xue Ye Xue Za Zhi
; 41(3): 239-244, 2020 Mar 14.
Artículo
en Zh
| MEDLINE | ID: mdl-32311895
12.
[Therapeutic effect of combined use of interferon alpha-1b, interleukin-2 and thalidomide on reversing minimal residual disease in acute myeloid leukemia].
Zhonghua Xue Ye Xue Za Zhi
; 40(2): 111-116, 2019 Feb 14.
Artículo
en Zh
| MEDLINE | ID: mdl-30831625
13.
[Comparison of clinical efficacy between first-generation and second-generation tyrosine kinase inhibitors based regimen in the treatment of patients with BCR-ABL positive acute lymphoblastic leukemia].
Zhonghua Xue Ye Xue Za Zhi
; 40(9): 738-743, 2019 Sep 14.
Artículo
en Zh
| MEDLINE | ID: mdl-31648474
14.
[Ibrutinib combined with CAR-T cells in the treatment of del (17p) chronic lymphocytic leukemia with BCL-2 inhibitor resistance: a case report and literature review].
Zhonghua Xue Ye Xue Za Zhi
; 40(9): 750-754, 2019 Sep 14.
Artículo
en Zh
| MEDLINE | ID: mdl-31648477
15.
[Retrospective analysis of the efficacy and safety of Venetoclax-based regimen in the treatment of 12 cases of acute myeloid leukemia with t (8; 21)].
Zhonghua Xue Ye Xue Za Zhi
; 44(6): 501-504, 2023 Jun 14.
Artículo
en Zh
| MEDLINE | ID: mdl-37550208
16.
[Clinical analysis of autologous hematopoietic stem cell transplantation in the treatment of advanced/recurrent nasal type extranodal NK/T-cell lymphoma].
Zhonghua Xue Ye Xue Za Zhi
; 39(7): 569-572, 2018 Jul 14.
Artículo
en Zh
| MEDLINE | ID: mdl-30122016
17.
[The expression of CRLF2 in adult Ph negative acute B lymphocytic leukemia and its prognostic significance].
Zhonghua Xue Ye Xue Za Zhi
; 39(10): 822-827, 2018 Oct 14.
Artículo
en Zh
| MEDLINE | ID: mdl-30369203
18.
[Synchronous lymphoma and carcinoma-clinical analyses of 17 patients].
Zhonghua Xue Ye Xue Za Zhi
; 39(4): 277-280, 2018 Apr 14.
Artículo
en Zh
| MEDLINE | ID: mdl-29779320
19.
[Sorafenib in combination with chemotherapy as first-line therapy for FLT3-ITD positive acute myeloid leukemia].
Zhonghua Xue Ye Xue Za Zhi
; 38(5): 415-420, 2017 May 14.
Artículo
en Zh
| MEDLINE | ID: mdl-28565742
20.
[The clinical safety and efficacy of the patients of acute myeloid leukemia with FLT3-ITD positive treated with sorafenib in combination with venetoclax and azactitidine regimen].
Zhonghua Xue Ye Xue Za Zhi
; 43(11): 956-959, 2022 11 14.
Artículo
en Zh
| MEDLINE | ID: mdl-36709189